Literature DB >> 22639229

Comparison of the D2 receptor regulation and neurotoxicant susceptibility of nigrostriatal dopamine neurons in wild-type and CB1/CB2 receptor knockout mice.

Tyrell J Simkins1, Kelly L Janis, Alison K McClure, Bahareh Behrouz, Samuel S Pappas, Andreas Lehner, Norbert E Kaminski, John L Goudreau, Keith J Lookingland, Barbara L F Kaplan.   

Abstract

Motor dysfunctions of Parkinson Disease (PD) are due to the progressive loss of midbrain nigrostriatal dopamine (NSDA) neurons. Evidence suggests a role for cannabinoid receptors in the neurodegeneration of these neurons following neurotoxicant-induced injury. This work evaluates NSDA neurons in CB1/CB2 knockout (KO) mice and tests the hypothesis that CB1/CB2 KO mice are more susceptible to neurotoxicant exposure. NSDA neuronal indices were assessed using unbiased stereological cell counting, high pressure liquid chromatography coupled with electrochemical detection or mass spectrometry, and Western blot. Results reveal that CB1 and CB2 cannabinoid receptor signaling is not necessary for the maintenance of a normally functioning NSDA neuronal system. Mice lacking CB1 and CB2 receptors were found to be equally susceptible to the neurotoxicant 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). These studies support the use of CB1/CB2 KO mice for investigating the cannabinoid receptor-mediated regulation of the NSDA neuronal system in models of PD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22639229      PMCID: PMC3479639          DOI: 10.1007/s11481-012-9375-y

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  14 in total

1.  Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.

Authors:  Robert E Drolet; Bahareh Behrouz; Keith J Lookingland; John L Goudreau
Journal:  Neurotoxicology       Date:  2004-09       Impact factor: 4.294

2.  WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Authors:  David A Price; Alex A Martinez; Alexandre Seillier; Wouter Koek; Yolanda Acosta; Elizabeth Fernandez; Randy Strong; Beat Lutz; Giovanni Marsicano; James L Roberts; Andrea Giuffrida
Journal:  Eur J Neurosci       Date:  2009-05-21       Impact factor: 3.386

3.  Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression.

Authors:  Matthew Benskey; Bahareh Behrouz; Johan Sunryd; Samuel S Pappas; Seung-Hoon Baek; Marianne Huebner; Keith J Lookingland; John L Goudreau
Journal:  Neurotoxicology       Date:  2012-02-09       Impact factor: 4.294

4.  Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

Authors:  Z Járai; J A Wagner; K Varga; K D Lake; D R Compton; B R Martin; A M Zimmer; T I Bonner; N E Buckley; E Mezey; R K Razdan; A Zimmer; G Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment.

Authors:  E Petroske; G E Meredith; S Callen; S Totterdell; Y S Lau
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

6.  The effects of targeted deletion of cannabinoid receptors CB1 and CB2 on intranasal sensitization and challenge with adjuvant-free ovalbumin.

Authors:  Barbara L F Kaplan; Jody E Lawver; Peer W F Karmaus; Thitirat Ngaotepprutaram; Neil P Birmingham; Jack R Harkema; Norbert E Kaminski
Journal:  Toxicol Pathol       Date:  2010-02-26       Impact factor: 1.902

Review 7.  Parkinson's disease: mechanisms and models.

Authors:  William Dauer; Serge Przedborski
Journal:  Neuron       Date:  2003-09-11       Impact factor: 17.173

8.  Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  V Jackson-Lewis; M Jakowec; R E Burke; S Przedborski
Journal:  Neurodegeneration       Date:  1995-09

9.  Unique responses to mitochondrial complex I inhibition in tuberoinfundibular dopamine neurons may impart resistance to toxic insult.

Authors:  B Behrouz; R E Drolet; Z A Sayed; K J Lookingland; J L Goudreau
Journal:  Neuroscience       Date:  2007-06-20       Impact factor: 3.590

10.  Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids.

Authors:  M Navarro; F Rodríguez de Fonseca; M L Hernández; J A Ramos; J J Fernández-Ruiz
Journal:  Pharmacol Biochem Behav       Date:  1994-01       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.